MM
Insider
Mark C. McKenna
DirectorMark C. McKenna (Director) filed 1 Form 4 report in the past 24 months (1 purchase, 0 sales), most often in Apogee Therapeutics, Inc. (APGE). Across 1 priced purchase filing, the average 21-session return was -19.3% from execution and -20.0% from disclosure (delay-adjusted; derived). The largest single filing was $991K of APGE (20,000 sh across 2 lots, as filed), executed Dec 12 2024.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
-19.3%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
-20.0%
same 1 filings, from disclosure
Filings, ttm
1
1 buys · 0 sells
Median delay
4d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$991K
shares × price, as filed
Last traded
Dec 12 2024
Filed Dec 16 2024
Median ADV $371.2M across their filed names
Open performance→Volume by month
Buys $991K
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 24 months
Most traded names
APGERecent filings
APGEPURCHASE
Apogee Therapeutics, Inc.
View filing →
$991K20,000 sh across 2 lots
Exec Dec 12 2024
Filed Dec 16 2024 · 5:30 PM ET